104 related articles for article (PubMed ID: 24029118)
1. Chronic neutrophilic leukaemia.
Bain BJ
Acta Haematol; 2014; 131(1):45. PubMed ID: 24029118
[No Abstract] [Full Text] [Related]
2. Presence of the JAK2 V617F mutation in a patient with chronic neutrophilic leukemia and effective response to interferon α-2b.
Zhang X; Pan J; Guo J
Acta Haematol; 2013; 130(1):44-6. PubMed ID: 23391844
[TBL] [Abstract][Full Text] [Related]
3. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia.
Lea NC; Lim Z; Westwood NB; Arno MJ; Gäken J; Mohamedali A; Mufti GJ
Leukemia; 2006 Jul; 20(7):1324-6. PubMed ID: 16673022
[No Abstract] [Full Text] [Related]
4. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.
Mc Lornan DP; Percy MJ; Jones AV; Cross NC; Mc Mullin MF
Haematologica; 2005 Dec; 90(12):1696-7. PubMed ID: 16330446
[TBL] [Abstract][Full Text] [Related]
5. Chronic neutrophilia associated with myeloma: is it clonal?
Nedeljkovic M; He S; Szer J; Juneja S
Leuk Lymphoma; 2014 Feb; 55(2):439-40. PubMed ID: 23713456
[No Abstract] [Full Text] [Related]
6. Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
Kako S; Kanda Y; Sato T; Goyama S; Noda N; Shoda E; Oshima K; Inoue M; Izutsu K; Watanabe T; Motokura T; Chiba S; Fukayama M; Kurokawa M
Am J Hematol; 2007 May; 82(5):386-90. PubMed ID: 17109389
[TBL] [Abstract][Full Text] [Related]
7. Chronic neutrophilic leukaemia.
Gan GG; Pasagna JF; Eow GI; Nadarajan VS
Singapore Med J; 2007 Mar; 48(3):e74-6. PubMed ID: 17342275
[TBL] [Abstract][Full Text] [Related]
8. Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia.
Meyer S; Feremans W; Cantiniaux B; Capel P; Huygen K; Dicato M
Am J Hematol; 1993 Aug; 43(4):307-9. PubMed ID: 8372813
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.
Helbig G; Stella-Holowiecka B; Majewski M; Lewandowska M; Holowiecki J
Haematologica; 2007 Nov; 92(11):e118-9. PubMed ID: 18024388
[TBL] [Abstract][Full Text] [Related]
10. Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.
Stoner RC; Press RD; Maxson JE; Tyner JW; Dao KT
Leukemia; 2020 Jun; 34(6):1684-1688. PubMed ID: 31844143
[No Abstract] [Full Text] [Related]
11. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
[No Abstract] [Full Text] [Related]
12. Chronic neutrophilic leukemia, a rare case of leukocytosis.
Wang X; Resendes NM; Shanahan L; Hutchinson L; Woda B; Cerny J
Leuk Res; 2020 Jul; 94():106384. PubMed ID: 32447046
[No Abstract] [Full Text] [Related]
13. Changes in allele frequencies of
Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
[No Abstract] [Full Text] [Related]
14. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
Hinze A; Rinke J; Hochhaus A; Ernst T
Ann Hematol; 2021 Feb; 100(2):581-584. PubMed ID: 32577845
[No Abstract] [Full Text] [Related]
15. A case of plasma cell neoplasm-associated chronic neutrophilic leukemia with ASXL1 and JAK2V617F mutations.
Lauw MIS; Hakim N; Arora S; Prakash S; Xie Y
Ann Hematol; 2022 Aug; 101(8):1879-1881. PubMed ID: 35419626
[No Abstract] [Full Text] [Related]
16. Next-generation sequencing panel for diagnosis and management of chronic neutrophilic leukaemia: a case report.
Mak KY; Au CH; Chan TL; Ma ESK; Chow EYD; Lin SY; Choi WWL
Hong Kong Med J; 2019 Jun; 25(3):248-250. PubMed ID: 31182673
[No Abstract] [Full Text] [Related]
17. Familial occurrence of chronic neutrophilic leukaemia.
Kojima K; Yasukawa M; Hara M; Nawa Y; Kimura Y; Narumi H; Fujita S
Br J Haematol; 1999 May; 105(2):428-30. PubMed ID: 10233414
[TBL] [Abstract][Full Text] [Related]
18. Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.
Larsen TS; Bjerrum OW; Pallisgaard N; Andersen MT; Møller MB; Hasselbalch HC
Ann Hematol; 2008 Oct; 87(10):847-50. PubMed ID: 18481066
[TBL] [Abstract][Full Text] [Related]
19. [New mutations in myeloproliferative neoplasms; 2014 update].
Kirito K
Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
[No Abstract] [Full Text] [Related]
20. Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach.
Foa P; Iurlo A; Saglio G; Guerrasio A; Capsoni F; Maiolo AT
Br J Haematol; 1991 Jun; 78(2):286-8. PubMed ID: 2064971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
